BOXED WARNING Hepatotoxicity (some fatal); not for onychomycosis or skin/Candida infections—use only when other antifungals unavailable/not tolerated; QT prolongation with certain coadministered drugs
FDA dosing
Population
Start
Target
Max
Systemic fungal infection
adult
200 mg QD
400 mg QD
Systemic fungal infection
children >2 yr
3.3-6.6 mg/kg QD
Renal Undefined
Hepatic Undefined
Instructions
Document infection (lab and clinical) before starting
Usual duration for systemic infection is 6 months; continue until active infection subsides
Not studied in children under 2 yr
Available strengths
tab 200 mg
cream 2 %
shampoo 1, 2 %
sol 0.01 g/mL
susp 20 mg/mL
foam 2 %
soap 1 g/100 g
Cautions
Hepatotoxicity, including fatalities—monitor liver function
QT prolongation/torsades with coadministered drugs
Anaphylaxis/anaphylactoid reactions
Adrenal insufficiency at higher doses (cortisol suppression)